Clinical Trial Update: Analysis of Circulating Tumor Markers in the Blood (ALCINA) [NA]

View source ↗

Summary

The ALCINA study analyzed circulating tumor markers in the blood of cancer patients and has completed its course.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Institut Curie | Conditions: Cancer | NA | Status: COMPLETED